Overview

EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension

Status:
Completed
Trial end date:
2018-06-29
Target enrollment:
Participant gender:
Summary
In accordance with the regulatory guidance this registry has been designed to collect information about the long-term safety of Adempas in real clinical practice outside the regulated environment of a controlled clinical study.
Details
Lead Sponsor:
Bayer
Treatments:
Riociguat